Archive for September, 2009

Sabine Vollmer

Munich Oktoberfest, here I come!

Friday, September 25, 2009, 4:47 am By No Comments | Post a Comment

The blog will go on vacation the next two weeks to sample the goods in Germany’s wine country southwest of Frankfurt and at the Munich Oktoberfest.

See you back here Oct. 12.

Sabine Vollmer

RTP Wrapup 9/25

Thursday, September 24, 2009, 4:48 pm By No Comments | Post a Comment

Micell Technologies receives $15 million from St. Jude Medical, GlaxoSmithKline curbs its funding educational programs that bring doctors up-to-date, Duke Genome Center gets a $19.5 million grant and a consortium of area universities and nonprofit organizations are chasing a piece of the $63 billion the Obama Administration wants to spend over the next six years on global health care programs.

Read more…

Sabine Vollmer

Where will tomorrow's energy come from?

Thursday, September 24, 2009, 12:37 pm By No Comments | Post a Comment

Remember cold fusion? Most scientists believe the dream of generating an abundance of cheap energy by fusing two atomic nuclei at room temperature is dead after a 1989 tabletop experiment couldn’t be repeated and its results were questioned.

Read more…

Sabine Vollmer

Triangle is first stop in U.S. global health revamp

Monday, September 21, 2009, 2:50 pm By 1 Comment | Post a Comment

When a Washington think tank went looking for ideas to influence how the U.S. might spend $63 billion in the next six years improving the health of people in poor countries, it came to North Carolina’s Research Triangle Park.

Read more…

Sabine Vollmer

RTP Weekahead 9/21

Sunday, September 20, 2009, 5:44 pm By No Comments | Post a Comment

Events taking place the week of Sept. 21 in the Research Triangle area that are open to the public:

Read more…

Sabine Vollmer

RTP Wrapup 9/18

Thursday, September 17, 2009, 7:13 pm By No Comments | Post a Comment

Salix Pharmaceuticals watches its stock soar and Pozen takes action to broaden the scope of the company while GlaxoSmithKline waits for regulatory approval of two vaccines.

Read more…

Sabine Vollmer

X-ray scanners get a nanotech makeover

Wednesday, September 16, 2009, 8:16 pm By No Comments | Post a Comment

Machines that scan luggage at airports and look inside the body still bear the imprint of Wilhelm Roentgen, the German physics professor who stumbled upon X-rays 114 years ago.

Read more…

Sabine Vollmer

Salix soars on rifaximin data

Wednesday, September 16, 2009, 5:11 am By No Comments | Post a Comment

Salix Pharmaceuticals, a Morrisville company that specializes in gastrointestinal treatments, has seen its shares rise nearly 50 percent in the past two days.

Investors rushed to trade the stock after Salix announced results from two late-stage studies Monday that showed rifaximin works better than placebo in treating non-constipation irritable bowel syndrome. Salix sells rifaximin for traveler’s diarrhea under the name Xifaxan.

Read more…

Sabine Vollmer

RTP Weekahead 9/14

Sunday, September 13, 2009, 5:35 pm By No Comments | Post a Comment

Events taking place the week of Sept. 14 in the Research Triangle area that are open to the public:

Read more…

Sabine Vollmer

RTP Wrapup 9/11

Thursday, September 10, 2009, 9:39 pm By No Comments | Post a Comment

GlaxoSmithKline gets good news on its Cervarix vaccine and bad news on its blockbuster asthma treatment Advair, the N.C. Biotechnology Center prepares to build a $10.4 million expansion with the help of private donations and Quintiles Transnational gets ready for Clinical Research Education Day at N.C. Central University.

Read more…